Vitamin B7 could help doctors see where transfused platelets go
NCT ID NCT07513532
First seen Apr 09, 2026 · Last updated Jun 22, 2026 · Updated 14 times
Summary
This study in 12 healthy volunteers tests whether biotin (vitamin B7) can be used to label platelets so they can be tracked after transfusion. Platelets are collected, labeled with biotin, stored for 3 days, then a small radioactive tag is added before returning them to the donor. Blood samples will measure how long the labeled platelets survive in circulation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Bloodworks Northwest Research Institute
RECRUITINGSeattle, Washington, 98102, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Biotin-labeled platelets
What this could lead to
If successful, this could provide a safer, simpler way to track transfused platelets in the body, improving transfusion medicine.
What could go wrong
This is a very early, small study in only 12 healthy people. It tests a labeling method, not a treatment, so it won't directly help patients yet.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.